Clonidine Extended-Release Tablets for Pediatric Patients With Attention-Deficit/Hyperactivity Disorder

Jain, Rakesh, Segal, Scott, Kollins, Scott H., Khayrallah, Moise·2011·Journal of the American Academy of Child & Adolescent Psychiatry
DOI 10.1016/j.jaac.2010.11.005

Cited by (142)

Items 101–142 of 142

  1. Risk Factors for Overweight in Children with Autism Spectrum Disorder
    Sabrina N. Grondhuis, Michael G. Aman · 2016 · Journal of Developmental and Physical Disabilities
  2. Pharmacotherapy for attention-deficit/hyperactivity disorder
    Bongseog Kim · 2019 · Journal of Korean Medical Association
  3. Neurodevelopmental Disorders: Attention Deficit Hyperactivity Disorder (ADHD)
    Jeffrey H. Newcorn, Beth Krone, David Coghill, Jeffrey M. Halperin · 2024 · Springer eBooks
  4. Tailored Transdermal Drug Delivery System for Pain Management: Development and Evaluation of Clonidine Hydrochloride/Sodium Montmorillonite Composite Patch
    Sourav Adhikary, Ashique Al Hoque, Manisheeta Ray, Pritha Pal, Mahua Ghosh Chaudhuri, Rajib Kumar Dey · 2024 · BioNanoScience
  5. Extended Release Alpha-2 Agonists for ADHD
    Crystal Thomas · 2013 · Child and Adolescent Psychopharmacology News
  6. Clonidine and guanfacine IR vs ER: Old drugs with “new” formulations
    Lyndsay Gormley, Amber Turner, Kathryn N. Freeland · 2014 · Mental Health Clinician
  7. Non-stimulant treatment of ADHD
    Juan D. Pedraza, Jeffrey H. Newcorn · 2014 · Cambridge University Press eBooks
  8. Chapter 41. Children and Adolescents
    Margery R. Johnson, Nicholas M. Hatzis, Amandeep Jutla · 2019 · American Psychiatric Association Publishing eBooks
  9. Efficacy and Safety of Extended-Release Clonidine Hydrochloride for Attention Deficit Hyperactivity Disorder in Chinese Children and Adolescents: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Yun Qian, Xiaoyan Ke, Feng Gao, Wenxiong Chen, Weige Wu, Yaping Li, Lijun Du, Huafang Li, Yasong Du · 2026 · Journal of Child and Adolescent Psychopharmacology
  10. Attention Deficit Hyperactivity Disorder Through The Life Cycle
    Anthony L. Rostain · 2012 · FOCUS The Journal of Lifelong Learning in Psychiatry
  11. Obsessive and Inattentive
    Michael S. Hanau, Eric A. Jenike · 2012 · Current psychiatry
  12. Evaluating clonidine response in children and adolescents with attention-deficit/hyperactivity disorder
    Meryem Özlem Kütük, Gulen Guler, Ali Evren Tufan, Mehmet Alı Sungur, Zehra Topal, Özgür Kütük · 2018 · AIMS Medical Science
  13. Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders
    Jessica Zammit, Vladimir Ferrafiat · 2022 · CNS Spectrums
  14. Adverse Events During Dosing of Delayed-release/Extended-release Methylphenidate: Learnings From the Open-label Phase of a Registration Trial and a Real-world Postmarketing Surveillance Program
    Martin A. Katzman, Victor Otcheretko, Michelle D. Po, Cassandra L. Uchida, Bev Incledon · 2023 · Clinical Therapeutics
  15. Pharmacological and Nonpharmacological Treatment of Insomnias, Parasomnias, and Circadian Rhythm Disorders Associated With ADHD
    M. Angriman, S. Cortese · 2019 · Sleep and ADHD
  16. Attention deficit hyperactivity disorder
    Steven M. Lazar, Robert G. Voigt · 2024 · Elsevier eBooks
  17. Children and Adolescents
    Margery R. Johnson, Nicholas Hatzis, Amandeep Jutla · 2019 · American Psychiatric Association Publishing eBooks
  18. Consider non-stimulants or adjunctive therapy when response to stimulants is inadequate in patients with attention-deficit/hyperactivity disorder
    Adis Medical Writers · 2014 · Drugs & Therapy Perspectives
  19. Clonidine extended-release tablets for the treatment of ADHD
    Joan Daughton, Lindsey Corr, Howard Yee Liu, Madeline West · 2012 · Neuropsychiatry
  20. New Additions to the Psychopharmacopia: Extended Release Formulations
    Marian W. Roman · 2011 · Issues in Mental Health Nursing
  21. [α2-Adrenergic agonists, and drugs for ADHD].
    H. Clement, E. Schulz · 2011 · Pharmazie in unserer Zeit
  22. Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants
    Adderall Xr · 2014
  23. THE OFF-LABEL USE OF ATYPICAL ANTIPSYCHOTICS AND ITS IMPACT ON ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
    Minji Sohn · 2014 · UKnowledge (University of Kentucky)
  24. Långtidsbehandling av ADHD : En litteraturstudie kring effekter av metylfenidat och atomoxetin vid minst sex månaders behandling
    Amanda Valter · 2016 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  25. Attention Deficit Hyperactivity Disorder in Appalachia: proposed methods to analyze and solve social and medical issues surrounding the disorder
    Alexis Rae Prillhart · 2017
  26. Applications of Item Response Theory to Clinical ADHD Research: Analysis of the Hierarchical Structure of ADHD Symptoms and Increased Precision of Treatment Effect Estimation
    Los Angeles · 2016
  27. Executive Function Disorders in Pediatric Neuropsychology: Attention-Deficit/Hyperactivity Disorder and Tourette Disorder
    Anthony L. Rostain, William C. Culbertson · 2019 · Springer eBooks
  28. Treatment of ADHD in Individuals With and Without Intellectual Disabilities
    Ryan N. Cummins, Sabrina Gretkierewicz, Adrienne Anderson, Jennifer Piscitello, Mary Lou Kelley · 2020 · Autism and child psychopathology series
  29. Attention-deficit/hyperactivity disorder and adverse health outcomes : from association to prevention
    Shihua Sun · 2020 · Figshare
  30. α2-Agonisten und adrenerge Pharmaka bei ADHS: Wirkmechanismen und klinische Studien
    Hans‐Willi Clement, Eberhard Schulz · 2011 · Pharmazie in unserer Zeit
  31. The 51st Annual National Institute of Mental Health (NIMH) New Clinical Drug Evaluation Unit (NCDEU) Meeting, Boca Raton, Florida, June 13–16, 2011Posters Most Relevant to Child and Adolescent Psychopharmacology
    2011 · Journal of Child and Adolescent Psychopharmacology
  32. The Neurological Perspective: Autism Spectrum Disorders and Other Developmental Disabilities
    Syed Ali Raza, Junaid Ansari, Rosario Maria S. Riel-Romero · 2022 · Autism and child psychopathology series
  33. Safety and efficacy of clonidine hydrochloride extended –release (CLON-XR) for treatment of attention deficit hyperactivity disorder in Chinese children and adolescents: a multi-center, placebo-controlled, randomized, double-blind study
    Yasong Du, Xiaoyan Ke, Feng Gao, Wenxiong Chen, Weige Wu, Yaping Li, Lijun Du, Ying Ye, Haijian Zhu, Linhui Cai et al. · 2023 · Research Square
  34. Quality Ratings for Psychotherapies and Efficacy Data for Medications
    2024 · American Academy of PediatricsItasca, IL eBooks
  35. The identification of new directions for the research of ADHD
    Andrew Burkhardt · 2023
  36. Cortical mechanisms of comorbidity between pain sensitization and attention-deficit/hyperactivity disorder (ADHD) in a mouse model
    Sarah Bou Sader Nehme · 2024 · theses.fr (ABES)
  37. Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?
    Maryam Tariq, Ann Genovese · 2026 · Journal of Child and Adolescent Psychopharmacology
  38. Relative Bioavailability of Once-Daily Clonidine XR Oral Suspension Versus Twice-Daily XR Tablets in Healthy Volunteers
    Rakesh Jain, Eman Rafla, Joseph C. Grieco, Matthew Witkovic, Jennifer Horng, Jim Potenziano · 2026 · Journal of Attention Disorders
  39. Cannabigerol, a minor phytocannabinoid, prevents behavioral changes induced by psychotomimetic drugs
    João Francisco Cordeiro Pedrazzi, A.J. Sales, Jaime E. C. Hallak, Antônio Waldo Zuardi, Guimarães F.S., E.A.Del Bel, J.A.S. Crippa · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  40. Historical development of ADHD from 1753 to 2026
    Farzad Salehpour, Francisco Gonzalez-Lima · 2026 · Frontiers in Psychology
  41. Clinically Meaningful Within-Patient Change in Core Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents Treated With Centanafadine: Results From Two Phase 3 Randomized Clinical Trials
    Caroline L. Ward, Dorothee Oberdhan, Na Jin, Taisa Skubiak, Judy van Stralen, Gregory W. Mattingly, Ann Catherine Childress · 2026 · Journal of Attention Disorders
  42. The Use of Clonidine in Patients With ADHD and Comorbid ODD
    Vidhi Vora, Ryan Worms, Luis Rodriguez, Talal Alhunayan, Rajat Sharma, Janvi Bhupendrakumar Patel, Grace Bach, Kashyap Panchal, Ahmed Tharwat Emara, Himani J Suthar et al. · 2026 · Annals of Clinical Psychiatry